Total Funding
90
58
Total FundingGrant raised
Growth Score 90 in past quarter
-2 pts
Heat Score 58 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
32223
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
- Benjamin Doranz: President & CEO
- Dawn Eringis: Business Development Officer
About the Company
The objective of Integral Molecular is to create and utilize novel technologies that promote therapy discoveries against challenging protein targets. With more than 20 years of experience focusing on membrane proteins and antibodies, the company's solutions have helped over 400 companies in research, medication discovery, and vaccine
development.